Literature DB >> 16979535

Osteoarthritis: rational approach to treating the individual.

Peter Jüni1, Stephan Reichenbach, Paul Dieppe.   

Abstract

Osteoarthritis (OA) is the most common form of joint disease and the leading cause of pain and physical disability in older people. Risk factors for incidence and progression of osteoarthritis vary considerably according to the type of joint. Disease assessment is difficult and the relationship between the radiographic severity of joint damage and the incidence and severity of pain is only modest. Psychosocial and socio-economic factors play an important role. This chapter will discuss four main guiding principles to the management of OA: (1) to avoid overtreating people with mild symptoms; (2) to attempt to avoid doing more harm than good ('primum non nocere'); (3) to base patient management on the severity of pain, disability and distress, and not on the severity of joint damage or radiographic change; and (4) to start with advice about simple measures that patients can take to help themselves, and only progress to interventions that require supervision or specialist knowledge if simple measures fail. Effect sizes derived from meta-analyses of large randomized trials in OA are only small to moderate for most therapeutic interventions, but they are still valuable for patients and clinically relevant for physicians. Joint replacement may be the only option with a large effect size, but is only appropriate for the relatively small number of people with OA who have advanced disease and severe symptoms. The key to successful management involves patient and health professionals working together to develop optimal treatment strategies for the individual.

Entities:  

Mesh:

Year:  2006        PMID: 16979535     DOI: 10.1016/j.berh.2006.05.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  70 in total

1.  The efficacy of peloid therapy in management of hand osteoarthritis: a pilot study.

Authors:  Meliha Kasapoğlu Aksoy; Lale Altan; Rıza Eröksüz; Burcu Metin Ökmen
Journal:  Int J Biometeorol       Date:  2017-08-04       Impact factor: 3.787

2.  Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials.

Authors:  Zhen-Han Deng; Chao Zeng; Ye Yang; Yu-Sheng Li; Jie Wei; Tuo Yang; Hui Li; Guang-Hua Lei
Journal:  Clin Rheumatol       Date:  2015-08-05       Impact factor: 2.980

3.  Tramadol for osteoarthritis.

Authors:  Karine Toupin April; Jacinthe Bisaillon; Vivian Welch; Lara J Maxwell; Peter Jüni; Anne Ws Rutjes; M Elaine Husni; Jennifer Vincent; Tania El Hindi; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2019-05-27

4.  Paracetamol versus placebo for knee and hip osteoarthritis.

Authors:  Amanda O Leopoldino; Gustavo C Machado; Paulo H Ferreira; Marina B Pinheiro; Richard Day; Andrew J McLachlan; David J Hunter; Manuela L Ferreira
Journal:  Cochrane Database Syst Rev       Date:  2019-02-25

5.  Power training in patients with knee osteoarthritis: a pilot study on feasibility and efficacy.

Authors:  Denis Pelletier; Cédric Gingras-Hill; Patrick Boissy
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

6.  History of previous knee surgery does not affect the clinical outcomes of primary total knee arthroplasty in an Asian population.

Authors:  Jason Beng Teck Lim; Bryan Loh; Hwei Chi Chong; Andrew Hwee Chye Tan
Journal:  Ann Transl Med       Date:  2016-08

7.  Acetylsalicylic acid combined with diclofenac inhibits cartilage degradation in rabbit models of osteoarthritis.

Authors:  Jianqiang Liu; Changshun Wu; Dong Wang; Laicheng Wang; Shui Sun
Journal:  Exp Ther Med       Date:  2016-08-01       Impact factor: 2.447

Review 8.  Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.

Authors:  Simon Wandel; Peter Jüni; Britta Tendal; Eveline Nüesch; Peter M Villiger; Nicky J Welton; Stephan Reichenbach; Sven Trelle
Journal:  BMJ       Date:  2010-09-16

Review 9.  The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.

Authors:  Eveline Nüesch; Sven Trelle; Stephan Reichenbach; Anne W S Rutjes; Elizabeth Bürgi; Martin Scherer; Douglas G Altman; Peter Jüni
Journal:  BMJ       Date:  2009-09-07

10.  Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.

Authors:  X Chevalier; J Jerosch; P Goupille; N van Dijk; F P Luyten; D L Scott; F Bailleul; K Pavelka
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.